This week, critical economic events include the U.S. Federal Reserve, European Central Bank, and Bank of Canada’s first 2025 meetings. Investors await comments from President Trump on tariffs. Market movements are likely, with earnings reports from Apple and Tesla and potential tariff announcements influencing economies. ECB’s potential rate cut and China-U.S. trade tensions also grab attention.
Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25
Biocon’s board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected
January 30, 2025